The influenza vaccine, developed by the St. Petersburg Research Institute of Vaccines and Serums of the Russian Federal Biomedical Agency, was issued a registration certificate in Nicaragua. This is the first step in the joint project by the Russian-Nicaraguan Intergovernmental Commission to support penetration by Russian immunobiological products of the Latin American markets. The registration